TLDR Biotech

TLDR Biotech
Archive
Page -73

The Latest Biotech & Pharma Updates

Biotech & Pharma Updates | July 29 - 30, 2025

🧬 GSK's committed to US investment ("tens of billions" in fact), Teva not bothered by tariffs, and Biogen, Eisai present positive long-term Leqembi data in Alzheimer's disease

Anis Fahandej-Sadi

Jul 30, 2025

Biotech & Pharma Updates | July 28 - 29, 2025

🧬 FDA's big CBER shake-up, Novo Nordisk dives while AstraZeneca soars, and massive cuts coming to Merck & Co. ($3B by EOY 2027)

Anis Fahandej-Sadi

Jul 29, 2025

Biotech & Pharma Updates | July 27 - 28, 2025

🧬 MapLight's $372.5M Series D, Adaptimmune sells-out (commercial assets)

Anis Fahandej-Sadi

Jul 28, 2025

Biotech & Pharma Updates | July 25 - 27, 2025

🧬 Hengrui & GSK link-up on 12 medicines, while Roche still in it for the gene therapy long-game

Anis Fahandej-Sadi

Jul 25, 2025

Biotech & Pharma Updates | July 23 - 24, 2025

🧬 3-peat of CGT layoffs, Eli Lilly goes in on molecular gates (up to $856M), and FDA (likely) wants new safety studies for Sarepta's Elevidys

Anis Fahandej-Sadi

Jul 24, 2025

Biotech & Pharma Updates | July 22 - 23, 2025

🧬 Dispatch Bio's $200M+ launch against solid tumors, FDA opens up 1-2 month priority review pathway, and Sarepta-partner Arrowhead still confident on state of $550M licensing deal

Anis Fahandej-Sadi

Jul 23, 2025

Biotech & Pharma Updates | July 21 - 22, 2025

🧬 Sanofi's $1.6B vaccine acquisition, while Replimmune's viral immunotherapy for melanoma lands an FDA rejection.

Anis Fahandej-Sadi

Jul 22, 2025

Biotech & Pharma Updates | July 20 - 21, 2025

🧬 Sarepta continues dominating headlines, while AstraZeneca and Biogen commit billions to US domestic manufacturing

Anis Fahandej-Sadi

Jul 21, 2025

Biotech & Pharma Updates | July 18 - 20, 2025

🧬 Sarepta Therapeutics to square off with the FDA on Elevidys gene therapy, while Moderna cancelled mRNA factory in Japan

Anis Fahandej-Sadi

Jun 18, 2025

Lowering CAR-T Costs: Paths to more affordable cell therapies

A long form piece by yours truly - originally published on Signals

Anis Fahandej-Sadi

May 16, 2025

Time for a Pause

Some hard truths about TLDR Biotech

Anis Fahandej-Sadi

May 07, 2025

Biotech & Pharma Updates | May 5 - 6, 2025

Bristol Myers Squibb pledges $40B for US R&D and manufacturing, NewLimit $130M Series B with ambitions to develop epigenetic drugs to extend healthy lifespan using AI and genomics, Trump orders FDA to streamline drug factory regulations and reduce building timeframes from 5-10 years + 34 more stories

Anis Fahandej-Sadi

First Back

1 2 3 4 5 6 7 8

Next Last